Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Yue Zhi Lee; Hsing Yu Hsu; Cheng Wei Yang; Yi Ling Lin; Sui Yuan Chang; Ruey Bing Yang; Jian Jong Liang; Tai Ling Chao; Chun Che Liao; Han Chieh Kao; Jang Yang Chang; Huey Kang Sytwu; Chiung Tong Chen; Shiow Ju Lee

doi:10.3390/pharmaceutics15020342

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Yue Zhi Lee
, Hsing Yu Hsu
, Cheng Wei Yang
, Yi Ling Lin
, Sui Yuan Chang
, Ruey Bing Yang
, Jian Jong Liang
, Tai Ling Chao
, Chun Che Liao
, Han Chieh Kao
, Jang Yang Chang
, Huey Kang Sytwu
, Chiung Tong Chen
, Shiow Ju Lee

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original language	English
Article number	342
Journal	Pharmaceutics
Volume	15
Issue number	2
DOIs	https://doi.org/10.3390/pharmaceutics15020342
Publication status	Published - Feb 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.3390/pharmaceutics15020342

Fingerprint

Dive into the research topics of 'Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)'. Together they form a unique fingerprint.

Cite this

Lee, Y. Z., Hsu, H. Y., Yang, C. W., Lin, Y. L., Chang, S. Y., Yang, R. B., Liang, J. J., Chao, T. L., Liao, C. C., Kao, H. C., Chang, J. Y., Sytwu, H. K., Chen, C. T., & Lee, S. J. (2023). Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511). Pharmaceutics, 15(2), Article 342. https://doi.org/10.3390/pharmaceutics15020342

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511). / Lee, Yue Zhi; Hsu, Hsing Yu; Yang, Cheng Wei et al.
In: Pharmaceutics, Vol. 15, No. 2, 342, 02.2023.

Research output: Contribution to journal › Comment/debate › peer-review

Lee, YZ, Hsu, HY, Yang, CW, Lin, YL, Chang, SY, Yang, RB, Liang, JJ, Chao, TL, Liao, CC, Kao, HC, Chang, JY, Sytwu, HK, Chen, CT & Lee, SJ 2023, 'Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)', Pharmaceutics, vol. 15, no. 2, 342. https://doi.org/10.3390/pharmaceutics15020342

@article{9e04cd2204724824afaa1302c6e0b50c,

title = "Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)",

abstract = "Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.",

author = "Lee, \{Yue Zhi\} and Hsu, \{Hsing Yu\} and Yang, \{Cheng Wei\} and Lin, \{Yi Ling\} and Chang, \{Sui Yuan\} and Yang, \{Ruey Bing\} and Liang, \{Jian Jong\} and Chao, \{Tai Ling\} and Liao, \{Chun Che\} and Kao, \{Han Chieh\} and Chang, \{Jang Yang\} and Sytwu, \{Huey Kang\} and Chen, \{Chiung Tong\} and Lee, \{Shiow Ju\}",

note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = feb,

doi = "10.3390/pharmaceutics15020342",

language = "English",

volume = "15",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "2",

}

TY - JOUR

T1 - Correction

T2 - The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

AU - Lee, Yue Zhi

AU - Hsu, Hsing Yu

AU - Yang, Cheng Wei

AU - Lin, Yi Ling

AU - Chang, Sui Yuan

AU - Yang, Ruey Bing

AU - Liang, Jian Jong

AU - Chao, Tai Ling

AU - Liao, Chun Che

AU - Kao, Han Chieh

AU - Chang, Jang Yang

AU - Sytwu, Huey Kang

AU - Chen, Chiung Tong

AU - Lee, Shiow Ju

PY - 2023/2

Y1 - 2023/2

N2 - Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

AB - Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

UR - https://www.scopus.com/pages/publications/85149407657

UR - https://www.scopus.com/pages/publications/85149407657#tab=citedBy

U2 - 10.3390/pharmaceutics15020342

DO - 10.3390/pharmaceutics15020342

M3 - Comment/debate

AN - SCOPUS:85149407657

SN - 1999-4923

VL - 15

JO - Pharmaceutics

JF - Pharmaceutics

IS - 2

M1 - 342

ER -

Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this